Michael O Okpara, Michaelone C Vaaltyn, Jessica L Watson, Mahama Alhassan, Fernando Albericio, Beatriz G de la Torre, David J Clarke, Clinton G L Veale, Adrienne L Edkins
{"title":"Hop-HSP90蛋白-蛋白相互作用的调节剂会破坏KSHV的溶解复制","authors":"Michael O Okpara, Michaelone C Vaaltyn, Jessica L Watson, Mahama Alhassan, Fernando Albericio, Beatriz G de la Torre, David J Clarke, Clinton G L Veale, Adrienne L Edkins","doi":"10.1021/acsinfecdis.4c00429","DOIUrl":null,"url":null,"abstract":"<p><p>The central role of the chaperome in maintaining cellular proteostasis has seen numerous viral families evolve to parasitically exploit host chaperones in their life cycle. The HSP90 chaperone protein and its cochaperone Hop have both individually been shown to be essential factors for Kaposi sarcoma-associated herpesvirus (KSHV) lytic replication. Given the fundamental regulatory role that protein-protein interactions (PPIs) play in cellular biology, we reasoned that disrupting the Hop-HSP90 PPI may provide a new host-based target for inhibiting KSHV lytic replication. This study expands upon a previous report of non-natural peptides, which were found to disrupt the association between the Hop<sub>TPR2A</sub> domain and its interacting HSP90<sub>CTD</sub>. Here, in addition to providing insight into the structure-activity relationships of PPI inhibition, we show disruption of the full-length Hop-HSP90 PPI. The inhibitory peptides selectively engaged the Hop<sub>TPR2A</sub> domain in cell lysates and when tethered to a cell-penetrating peptide acted as noncytotoxic inhibitors of KSHV lytic replication by lowering the viral load, preventing the production of infectious virions, and reducing the expression of KSHV lytic genes. In addition to tentative evidence of Hop-HSP90 PPI as a much-needed target for KSHV drug discovery, this study represents an important step in understanding viral interactions with the host proteostasis machinery.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":" ","pages":"3853-3867"},"PeriodicalIF":4.0000,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11555673/pdf/","citationCount":"0","resultStr":"{\"title\":\"Modulators of the Hop-HSP90 Protein-Protein Interaction Disrupt KSHV Lytic Replication.\",\"authors\":\"Michael O Okpara, Michaelone C Vaaltyn, Jessica L Watson, Mahama Alhassan, Fernando Albericio, Beatriz G de la Torre, David J Clarke, Clinton G L Veale, Adrienne L Edkins\",\"doi\":\"10.1021/acsinfecdis.4c00429\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The central role of the chaperome in maintaining cellular proteostasis has seen numerous viral families evolve to parasitically exploit host chaperones in their life cycle. The HSP90 chaperone protein and its cochaperone Hop have both individually been shown to be essential factors for Kaposi sarcoma-associated herpesvirus (KSHV) lytic replication. Given the fundamental regulatory role that protein-protein interactions (PPIs) play in cellular biology, we reasoned that disrupting the Hop-HSP90 PPI may provide a new host-based target for inhibiting KSHV lytic replication. This study expands upon a previous report of non-natural peptides, which were found to disrupt the association between the Hop<sub>TPR2A</sub> domain and its interacting HSP90<sub>CTD</sub>. Here, in addition to providing insight into the structure-activity relationships of PPI inhibition, we show disruption of the full-length Hop-HSP90 PPI. The inhibitory peptides selectively engaged the Hop<sub>TPR2A</sub> domain in cell lysates and when tethered to a cell-penetrating peptide acted as noncytotoxic inhibitors of KSHV lytic replication by lowering the viral load, preventing the production of infectious virions, and reducing the expression of KSHV lytic genes. In addition to tentative evidence of Hop-HSP90 PPI as a much-needed target for KSHV drug discovery, this study represents an important step in understanding viral interactions with the host proteostasis machinery.</p>\",\"PeriodicalId\":17,\"journal\":{\"name\":\"ACS Infectious Diseases\",\"volume\":\" \",\"pages\":\"3853-3867\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2024-11-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11555673/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1021/acsinfecdis.4c00429\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acsinfecdis.4c00429","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/30 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
摘要
伴侣体在维持细胞蛋白稳态方面发挥着核心作用,因此许多病毒家族都在其生命周期中寄生于宿主伴侣体。研究表明,HSP90伴侣蛋白及其辅助伴侣Hop都是卡波西肉瘤相关疱疹病毒(KSHV)溶解复制的重要因素。鉴于蛋白质-蛋白质相互作用(PPIs)在细胞生物学中发挥着根本性的调控作用,我们推断破坏 Hop-HSP90 PPI 可能会为抑制 KSHV 溶解复制提供一个基于宿主的新靶点。本研究扩展了之前关于非天然肽的报道,发现非天然肽能破坏 HopTPR2A 结构域与其相互作用的 HSP90CTD 之间的关联。在这里,除了深入了解 PPI 抑制的结构-活性关系外,我们还展示了对全长 Hop-HSP90 PPI 的破坏。这些抑制肽选择性地与细胞裂解液中的 HopTPR2A 结构域结合,当与细胞穿透肽连接时,通过降低病毒载量、阻止传染性病毒的产生和减少 KSHV 致死基因的表达,成为 KSHV 致死复制的非细胞毒性抑制剂。除了初步证明Hop-HSP90 PPI是KSHV药物发现急需的靶点外,这项研究还代表了了解病毒与宿主蛋白稳态机制相互作用的重要一步。
Modulators of the Hop-HSP90 Protein-Protein Interaction Disrupt KSHV Lytic Replication.
The central role of the chaperome in maintaining cellular proteostasis has seen numerous viral families evolve to parasitically exploit host chaperones in their life cycle. The HSP90 chaperone protein and its cochaperone Hop have both individually been shown to be essential factors for Kaposi sarcoma-associated herpesvirus (KSHV) lytic replication. Given the fundamental regulatory role that protein-protein interactions (PPIs) play in cellular biology, we reasoned that disrupting the Hop-HSP90 PPI may provide a new host-based target for inhibiting KSHV lytic replication. This study expands upon a previous report of non-natural peptides, which were found to disrupt the association between the HopTPR2A domain and its interacting HSP90CTD. Here, in addition to providing insight into the structure-activity relationships of PPI inhibition, we show disruption of the full-length Hop-HSP90 PPI. The inhibitory peptides selectively engaged the HopTPR2A domain in cell lysates and when tethered to a cell-penetrating peptide acted as noncytotoxic inhibitors of KSHV lytic replication by lowering the viral load, preventing the production of infectious virions, and reducing the expression of KSHV lytic genes. In addition to tentative evidence of Hop-HSP90 PPI as a much-needed target for KSHV drug discovery, this study represents an important step in understanding viral interactions with the host proteostasis machinery.
期刊介绍:
ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to:
* Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials.
* Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets.
* Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance.
* Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents.
* Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota.
* Small molecule vaccine adjuvants for infectious disease.
* Viral and bacterial biochemistry and molecular biology.